ANDREW S. MASLAN

Corporate Board Profile

Tech Score: 0/100

← Back to All Directors

Nuo Therapeutics, Inc.

Filing Date Source Excerpt
2012-04-16 Andrew S. Maslan - Chief Financial Officer of the Company. Includes 367,275 shares Mr. Maslan may acquire upon the exercise of stock options approved by the Board and issued under the Company’s Long-Term Incentive Plan and warrants.
2013-04-26 Andrew S. Maslan - Includes 401,218 shares Mr. Maslan may acquire upon the exercise of stock options approved by the Board and issued under the Company’s Long-Term Incentive Plan and warrants. Mr. Maslan tendered his resignation as the Company’s Chief Financial Officer on March 29, 2013, effective as of May 10, 2013.

Source material: SEC submissions metadata and DEF 14A proxy filings from EDGAR. Last updated: 2026-03-22